Sign In

Yusuf Sherwani

Co-Founder & CEO at Pelago (formerly Quit Genius)

Yusuf Sherwani, M.D. is the Co-Founder and CEO of Pelago, formerly known as Quit Genius.1 He is based in New York and has been leading the company since April 2017.1

Professional Background

Yusuf has a strong background in both medicine and entrepreneurship. He holds a medical degree and has experience in clinical research. Some key points about his professional journey include:

  • Current Role: Co-Founder and CEO at Pelago (formerly Quit Genius) since April 20171
  • Previous Experience:
    • Clinical Entrepreneur Fellow at NHS England (September 2017 - December 2020)1
    • Clinical Research Scholar at Wellcome Trust (July 2014 - September 2014)1

Education and Achievements

Yusuf's educational background includes studying at Imperial College London.1 He has received several honors and awards for his academic and entrepreneurial achievements:

  • Imperial College Business School Prize for Best Group Research Project Performance on the IBSc in Management1
  • Imperial College-Santander Entrepreneurship Prize1
  • Wellcome Trust Biomedical Vacation Scholarship1

These accolades highlight his excellence in both medical research and business management, which likely contributed to his success in founding and leading Pelago (Quit Genius).

Highlights

Aug 8 · linkedin

Our 2024 Annual State of Substance Use Management Trend Report reveals a clear demand for more honest dialogue about drug and alcohol use, as well as a strong desire for better support systems.

In our second iteration of this survey, we found that although more than half of workers surveyed believe employer support for substance and alcohol issues is crucial, only 14% report having access to such a benefit.

Employers have a unique opportunity to create and foster recovery-ready workplaces that reduce stigma and provide essential support and recovery resources.

By embracing comprehensive substance use management strategies, we can make significant strides in improving employee health and productivity. Read more about our findings and how you can take action in our full report, linked in the comments.

Jul 22 · linkedin

Partnering with Lumen Technologies has been incredibly inspiring.

Their commitment to destigmatizing substance use in the workplace aligns perfectly with our mission at Pelago.

The results speak for themselves: a robust 34% engagement rate in our Substance Use Management program and a significant 2.1 ROI.

More than the metrics, it's the personal stories that best highlight the impact Lumen and Pelago are making together. We've witnessed incredible transformations, like Julie’s, who completely revamped her relationship with alcohol.

It's partnerships like these that reinforce the power of collaboration and the importance of supportive, stigma-free environments.

I'm truly proud of what we've achieved together and excited for what lies ahead.

Related Questions

What inspired Yusuf Sherwani to start Quit Genius?
What is the mission of Pelago?
How did Yusuf Sherwani's experience at Imperial College influence his career?
What are some notable achievements of Yusuf Sherwani in his role at Pelago?
How did Yusuf Sherwani's role at NHS England shape his entrepreneurial journey?
Yusuf Sherwani
Yusuf Sherwani, photo 1
Yusuf Sherwani, photo 2
Add to my network

Experience

Co-Founder & CEO at Pelago (formerly Quit Genius) (April 2017 - Present)
Clinical Entrepreneur Fellow at NHS England (September 2017 - December 2020), Clinical Research Scholar at Wellcome Trust (July 2014 - September 2014)

Location

New York, New York, United States